The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma

NCT06609850 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Hepatocellular Carcinoma
Lenvatinib
Local Therapy
Ablation
Systemic Therapy

Interventions

PROCEDURE: TACE
PROCEDURE: Ablation
DRUG: Lenvatinb

Sponsor

Sun Yat-sen University

Collaborators

[object Object]